Compounds > bromopyruvate
Page last updated: 2024-08-25

bromopyruvate and Malignant Neurilemmoma

bromopyruvate has been researched along with Malignant Neurilemmoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Harder, A; Linke, C; Wösle, M1

Other Studies

1 other study(ies) available for bromopyruvate and Malignant Neurilemmoma

ArticleYear
Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.
    BMC cancer, 2020, Sep-18, Volume: 20, Issue:1

    Topics: Cell Proliferation; Enzyme Inhibitors; Humans; Metabolic Networks and Pathways; Neurofibrosarcoma; Pyruvates

2020